Company Filing History:
Years Active: 2007
Title: Innovator Spotlight: Christine Baumgartner
Introduction
Christine Baumgartner is a remarkable inventor based in Munich, Germany, who has made significant contributions to the field of medical research. With a strong focus on heart failure, she has dedicated her work to developing innovative solutions that can improve the lives of patients suffering from this condition.
Latest Patents
Christine holds a patent that centers on the "Use of EDG2 receptor in an animal model of heart failure." This patent outlines how mammalian myocardial cells transformed with the G protein-coupled receptor EDG2 can be utilized in an animal model to study heart failure. This innovation showcases her commitment to advancing medical knowledge and treatment options.
Career Highlights
Christine is affiliated with Sanofi-Aventis Deutschland GmbH, a prominent pharmaceutical company known for its focus on healthcare and innovative therapies. Her work at this institution allows her to collaborate with experts and contribute to groundbreaking research in the medical field.
Collaborations
Throughout her career, Christine has had the opportunity to work alongside esteemed colleagues, including Evi Kostenis and Paulus Wohlfart. Their combined expertise fosters an environment of creativity and innovation, driving forward the boundaries of research in heart health.
Conclusion
Christine Baumgartner stands as an inspiring figure in the realm of medical inventions. Her pioneering patent work and collaborations highlight her significant role in enhancing our understanding and treatment of heart failure. As the field evolves, her contributions hold promise for future advancements in medical science.